Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perinatal/Neonatal Case Presentation
  • Published:

Perinatal/Neonatal Case Presentation

Mucopolysaccharidosis Type VII Presenting With Isolated Neonatal Ascites

Abstract

Mucopolysaccharidosis Type VII (MPS VII) is a lysosomal storage disease caused by a deficiency of the enzyme, β-glucuronidase. MPS VII has a wide variation in phenotypic expression, including presentation in the neonatal period with nonimmune hydrops fetalis. We report a neonate with MPS VII who initially presented with marked isolated ascites not associated with hydrops fetalis. This appears to be a novel finding in patients with MPS VII.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Casal ML, Wolfe JH . Mucopolysaccharidosis type VII in the developing mouse fetus. Pediatr Res 2000; 47: 750–6.

    Article  CAS  Google Scholar 

  2. Sheridan O, Wortman J, Harvey C, Hayden J, Haskins M . Craniofacial abnormalities in animal models of mucopolysaccharidoses I, VI, and VII. J Craniofac Genet Dev Biol 1994; 14: 7–15.

    CAS  PubMed  Google Scholar 

  3. Nelson A, Peterson L, Frampton B, Sly WS . Mucopolysaccharidosis VII (beta-glucuronidase deficiency) presenting as nonimmune hydrops fetalis. J Pediatr 1982; 101: 574–6.

    Article  CAS  Google Scholar 

  4. Molyneux AJ, Blair E, Coleman N, Daish P . Mucopolysaccharidosis type VII associated with hydrops fetalis: histopathological and ultrastructural features with genetic implications. J Clin Pathol 1997; 50: 252–4.

    Article  CAS  Google Scholar 

  5. Kagie MJ, Kleijer WJ, Huijmans JG, Maaswinkel-Mooy P, Kanhai HH . Beta-glucuronidase deficiency as a cause of fetal hydrops. Am J Med Genet 1992; 42: 693–5.

    Article  CAS  Google Scholar 

  6. Winn HN, Stiller R, Grannum PA, Crane JC, Coster B, Romero R . Isolated fetal ascites: prenatal diagnosis and management. Am J Perinatol 1990; 7: 370–3.

    Article  CAS  Google Scholar 

  7. Gillan JE, Lowden JA, Gaskin K, Cutz E . Congenital ascites as a presenting sign of lysosomal storage disease. J Pediatr 1984; 104: 225–31.

    Article  CAS  Google Scholar 

  8. Wenger DA, Williams C . Screening for lysosomal disorders. In: Hommes FA, editor. Techniques in Diagnostic Human Biochemical Genetics: A Laboratory Manual. New York: Wiley. 1990. pp. 587–617.

    Google Scholar 

  9. Moore TR, Tipton EE . Amniotic fluid and nonimmune hydrops fetalis. In: Fanaroff AA, Martin RJ, editors. Neonatal–Perinatal Medicine. Diseases of the Fetus and Infant. St. Louis: Anne S. Patterson. 1997. p. 312–26 (Vol. 1).

    Google Scholar 

  10. Machin GA, et al. Diseases causing fetal and neonatal ascites. Pediatr Pathol 1985; 4: 195–211.

    Article  CAS  Google Scholar 

  11. Woodall DL, Birken GA, Williamson K, Lobe TE . Isolated fetal–neonatal abdominal ascites: a sign of intrauterine intussusception. J Pediatr Surg 1987; 22: 506–7.

    Article  CAS  Google Scholar 

  12. Abu-Dalu KI, Tamary H, Livni N, Rivkind AI, Yatziv S . GM1 gangliosidosis presenting as neonatal ascites. J Pediatr 1982; 100: 940–3.

    Article  CAS  Google Scholar 

  13. Daneman A, Stringer D, Reilly BJ . Neonatal ascites due to lysosomal storage disease. Radiology 1983; 149: 463–7.

    Article  CAS  Google Scholar 

  14. Daly TM, Ohlemiller KK, Roberts MS, Vogler CA, Sands MS . Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer. Gene Ther 2001; 8: 1291–8.

    Article  CAS  Google Scholar 

  15. Vogler C, Barker J, Sands MS, Levy B, Galvin N, Sly WS . Murine mucopolysaccharidosis VII: impact of therapies on the phenotype, clinical course, and pathology in a model of a lysosomal storage disease. Pediatr Dev Pathol 2001; 4: 421–33.

    Article  CAS  Google Scholar 

  16. Bonduelle M, Lissens W, Goossens A, et al. Lysosomal storage diseases presenting as transient or persistent hydrops fetalis. Genet Couns 1991; 2: 227–32.

    CAS  PubMed  Google Scholar 

  17. Sly WS, Quinton BA, McAlister WH, Rimoin DL . Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. J Pediatr 1973; 82: 249–57.

    Article  CAS  Google Scholar 

  18. Beaudet AL, DiFerrante NM, Ferry GD, Nichols BL Jr, Mullins CE . Variation in the phenotypic expression of beta-glucuronidase deficiency. J Pediatr 1975; 86: 388–94.

    Article  CAS  Google Scholar 

  19. Sferra TJ, Qu G, McNeely D, et al. Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse. Hum Gene Ther 2000; 11: 507–19.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank W.B. Cumming (Department of Radiology) for his assistance with reviewing the plain films and magnetic resonance images, C.A. Williams (Division of Genetics) for his assistance with the diagnosis and outpatient management of the patient, and the Biomedical Resource Services at the University of Florida Health Science Center for preparing the photograph.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saxonhouse, M., Behnke, M., Williams, J. et al. Mucopolysaccharidosis Type VII Presenting With Isolated Neonatal Ascites. J Perinatol 23, 73–75 (2003). https://doi.org/10.1038/sj.jp.7210844

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7210844

Search

Quick links